Publications by authors named "David Bolong"

Claim this Profile
E
Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study.
Małgorzata Baka-Ostrowska, David T Bolong, Cristian Persu, Camilla Tøndel, Achim Steup

Neurourol Urodyn· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies.
Israel Franco, Piet Hoebeke, Małgorzata Baka-Ostrowska, David Bolong, Leon N Davies

J Pediatr Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey.
Lap-Yin Ho, Peggy Sau-Kwan Chu, David Terrence Consigliere, Zulkifli Md Zainuddin, David Bolong

World J Urol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presenting manifestations of eosinophilic cystitis in two Filipino children.
Paul Joseph T Galutira, Beatrice B Canonigo, Ma Rosario F Cabansag, David T Bolong, Remedios C Ong

Int Urol Nephrol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis